PMC:2664230 / 21746-22290 JSON TXT

Annnotations TAB JSON ListView MergeView

bionlp-st-ge-2016-reference

{"project":"bionlp-st-ge-2016-reference","denotations":[{"id":"T8346","span":{"begin":158,"end":161},"obj":"Protein"}],"namespaces":[{"prefix":"_base","uri":"http://bionlp.dbcls.jp/ontology/ge.owl#"}],"text":"This group also demonstrated that forskolin did not inhibit the DNA-binding activity of NF-κB and that CREB was not involved in forskolin-induced decrease in p65 transcriptional activity.33 Similar results were reported by Ollivier et al. using THP-1 cells and endothelial cells treated with forskolin or dibutyryl cAMP, two agents known to function through cAMP elevation and subsequent PKA activation.9 The differences between our results and those mentioned above may be explained by the use of different cell types and exogenous stimulants."}

2_test

{"project":"2_test","denotations":[{"id":"18568240-12230568-22101135","span":{"begin":187,"end":189},"obj":"12230568"},{"id":"18568240-8702838-22101136","span":{"begin":403,"end":404},"obj":"8702838"}],"text":"This group also demonstrated that forskolin did not inhibit the DNA-binding activity of NF-κB and that CREB was not involved in forskolin-induced decrease in p65 transcriptional activity.33 Similar results were reported by Ollivier et al. using THP-1 cells and endothelial cells treated with forskolin or dibutyryl cAMP, two agents known to function through cAMP elevation and subsequent PKA activation.9 The differences between our results and those mentioned above may be explained by the use of different cell types and exogenous stimulants."}

bionlp-st-ge-2016-spacy-parsed

GO-BP

{"project":"GO-BP","denotations":[{"id":"T9859","span":{"begin":162,"end":177},"obj":"http://purl.obolibrary.org/obo/GO_0006351"},{"id":"T9898","span":{"begin":388,"end":391},"obj":"http://purl.obolibrary.org/obo/GO_0004691"}],"text":"This group also demonstrated that forskolin did not inhibit the DNA-binding activity of NF-κB and that CREB was not involved in forskolin-induced decrease in p65 transcriptional activity.33 Similar results were reported by Ollivier et al. using THP-1 cells and endothelial cells treated with forskolin or dibutyryl cAMP, two agents known to function through cAMP elevation and subsequent PKA activation.9 The differences between our results and those mentioned above may be explained by the use of different cell types and exogenous stimulants."}

GO-MF

{"project":"GO-MF","denotations":[{"id":"T10039","span":{"begin":388,"end":391},"obj":"http://purl.obolibrary.org/obo/GO_0004691"},{"id":"T10050","span":{"begin":64,"end":75},"obj":"http://purl.obolibrary.org/obo/GO_0003677"},{"id":"T10054","span":{"begin":68,"end":75},"obj":"http://purl.obolibrary.org/obo/GO_0005488"}],"text":"This group also demonstrated that forskolin did not inhibit the DNA-binding activity of NF-κB and that CREB was not involved in forskolin-induced decrease in p65 transcriptional activity.33 Similar results were reported by Ollivier et al. using THP-1 cells and endothelial cells treated with forskolin or dibutyryl cAMP, two agents known to function through cAMP elevation and subsequent PKA activation.9 The differences between our results and those mentioned above may be explained by the use of different cell types and exogenous stimulants."}

GO-CC

{"project":"GO-CC","denotations":[{"id":"T10066","span":{"begin":251,"end":256},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T10067","span":{"begin":273,"end":278},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T10075","span":{"begin":388,"end":391},"obj":"http://purl.obolibrary.org/obo/GO_0005952"}],"text":"This group also demonstrated that forskolin did not inhibit the DNA-binding activity of NF-κB and that CREB was not involved in forskolin-induced decrease in p65 transcriptional activity.33 Similar results were reported by Ollivier et al. using THP-1 cells and endothelial cells treated with forskolin or dibutyryl cAMP, two agents known to function through cAMP elevation and subsequent PKA activation.9 The differences between our results and those mentioned above may be explained by the use of different cell types and exogenous stimulants."}

sentences

{"project":"sentences","denotations":[{"id":"T8392","span":{"begin":0,"end":544},"obj":"Sentence"},{"id":"T148","span":{"begin":0,"end":544},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"This group also demonstrated that forskolin did not inhibit the DNA-binding activity of NF-κB and that CREB was not involved in forskolin-induced decrease in p65 transcriptional activity.33 Similar results were reported by Ollivier et al. using THP-1 cells and endothelial cells treated with forskolin or dibutyryl cAMP, two agents known to function through cAMP elevation and subsequent PKA activation.9 The differences between our results and those mentioned above may be explained by the use of different cell types and exogenous stimulants."}

events-check-again

{"project":"events-check-again","denotations":[{"id":"T10629","span":{"begin":158,"end":161},"obj":"Protein"}],"text":"This group also demonstrated that forskolin did not inhibit the DNA-binding activity of NF-κB and that CREB was not involved in forskolin-induced decrease in p65 transcriptional activity.33 Similar results were reported by Ollivier et al. using THP-1 cells and endothelial cells treated with forskolin or dibutyryl cAMP, two agents known to function through cAMP elevation and subsequent PKA activation.9 The differences between our results and those mentioned above may be explained by the use of different cell types and exogenous stimulants."}

bionlp-st-ge-2016-reference-tees

{"project":"bionlp-st-ge-2016-reference-tees","denotations":[{"id":"T10218","span":{"begin":88,"end":93},"obj":"Protein"},{"id":"T10219","span":{"begin":103,"end":107},"obj":"Protein"},{"id":"T10220","span":{"begin":158,"end":161},"obj":"Protein"},{"id":"T10221","span":{"begin":388,"end":391},"obj":"Protein"},{"id":"T10222","span":{"begin":52,"end":59},"obj":"Negative_regulation"},{"id":"T10223","span":{"begin":146,"end":154},"obj":"Negative_regulation"}],"relations":[{"id":"R8283","pred":"themeOf","subj":"T10218","obj":"T10222"},{"id":"R8284","pred":"themeOf","subj":"T10220","obj":"T10223"}],"text":"This group also demonstrated that forskolin did not inhibit the DNA-binding activity of NF-κB and that CREB was not involved in forskolin-induced decrease in p65 transcriptional activity.33 Similar results were reported by Ollivier et al. using THP-1 cells and endothelial cells treated with forskolin or dibutyryl cAMP, two agents known to function through cAMP elevation and subsequent PKA activation.9 The differences between our results and those mentioned above may be explained by the use of different cell types and exogenous stimulants."}

bionlp-st-ge-2016-uniprot

{"project":"bionlp-st-ge-2016-uniprot","denotations":[{"id":"T9742","span":{"begin":103,"end":107},"obj":"Q8TEY5"},{"id":"T9743","span":{"begin":103,"end":107},"obj":"Q02930"},{"id":"T9744","span":{"begin":103,"end":107},"obj":"P18848"},{"id":"T9745","span":{"begin":103,"end":107},"obj":"P16220"},{"id":"T9746","span":{"begin":103,"end":107},"obj":"P15336"},{"id":"T9747","span":{"begin":103,"end":107},"obj":"O43889"},{"id":"T9748","span":{"begin":158,"end":161},"obj":"P21579"},{"id":"T9749","span":{"begin":158,"end":161},"obj":"Q04206"}],"namespaces":[{"prefix":"_base","uri":"http://www.uniprot.org/uniprot/"}],"text":"This group also demonstrated that forskolin did not inhibit the DNA-binding activity of NF-κB and that CREB was not involved in forskolin-induced decrease in p65 transcriptional activity.33 Similar results were reported by Ollivier et al. using THP-1 cells and endothelial cells treated with forskolin or dibutyryl cAMP, two agents known to function through cAMP elevation and subsequent PKA activation.9 The differences between our results and those mentioned above may be explained by the use of different cell types and exogenous stimulants."}

test2

{"project":"test2","denotations":[{"id":"T8243","span":{"begin":138,"end":145},"obj":"Positive_regulation"},{"id":"T8244","span":{"begin":146,"end":154},"obj":"Negative_regulation"},{"id":"T8245","span":{"begin":158,"end":161},"obj":"Protein"},{"id":"T8246","span":{"begin":162,"end":177},"obj":"Transcription"}],"relations":[{"id":"R6753","pred":"themeOf","subj":"T8244","obj":"T8243"},{"id":"R6754","pred":"themeOf","subj":"T8245","obj":"T8246"},{"id":"R6755","pred":"themeOf","subj":"T8246","obj":"T8244"}],"text":"This group also demonstrated that forskolin did not inhibit the DNA-binding activity of NF-κB and that CREB was not involved in forskolin-induced decrease in p65 transcriptional activity.33 Similar results were reported by Ollivier et al. using THP-1 cells and endothelial cells treated with forskolin or dibutyryl cAMP, two agents known to function through cAMP elevation and subsequent PKA activation.9 The differences between our results and those mentioned above may be explained by the use of different cell types and exogenous stimulants."}

PMC:2664230 / 21746-22290 JSONTXT

Annnotations TAB JSON ListView MergeView

PMC:2664230 / 21746-22290 JSON TXT